Teratogenic Risk Impact and Mitigation (TRIM): Study Protocol for the Development of a Decision Support Tool to Prioritize Medications for Risk Mitigation.
Saved in:
| Title: | Teratogenic Risk Impact and Mitigation (TRIM): Study Protocol for the Development of a Decision Support Tool to Prioritize Medications for Risk Mitigation. |
|---|---|
| Authors: | Winterstein AG; Department of Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL, USA. almut@ufl.edu.; Center for Drug Evaluation and Safety, University of Florida, Gainesville, FL, USA. almut@ufl.edu.; Department of Epidemiology, University of Florida, Gainesville, FL, USA. almut@ufl.edu., Ewig CLY; Department of Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL, USA., Wang Y; Department of Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL, USA.; Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, USA., Smolinski NE; Department of Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL, USA., Toyserkani GA; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., LaCivita C; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Lackey L; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Eggers S; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Zhou EH; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Diaby V; Health Economics and Value Evidence Partnership, Otsuka Pharmaceutical Development Corporation Inc, Princeton, NJ, USA., Sarayani A; Janssen Research and Development, Johnson & Johnson, Brisbane, CA, USA., Thai T; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., Maro JC; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., Rasmussen SA; Department of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA. |
| Source: | Drug safety [Drug Saf] 2025 Feb; Vol. 48 (2), pp. 107-117. Date of Electronic Publication: 2024 Nov 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1179-1942 |
|---|---|
| DOI: | 10.1007/s40264-024-01488-4 |
